- Insider Monkey•18 days ago
At the end of last week, female healthcare focused biotech company TherapeuticsMD Inc (NYSEMKT:TXMD) submitted a new drug application (NDA) to the FDA for its lead development candidate, Yuvvexy. The drug is targeting a condition called vulvar and vaginal atrophy (VVA), and specifically, a symptom of this condition called dyspareunia, which is moderate-to-severe vaginal pain […]
- Capital Cube•22 days agoTherapeuticsMD, Inc. breached its 50 day moving average in a Bearish Manner : TXMD-US : July 8, 2016
Click here to see latest analysis*Disclaimer : This is as of previous day’s closing price.Technical IndicatorsBelow is a quick look at 5 technical indicators for TherapeuticsMD, Inc.. More studies are available on the Technical Chart.IndicatorSignalClosing Price above/below 50 Day Moving AverageBearishClosing Price above/below 200 Day Moving AverageBullish50 Day Moving Average above/below 200 Day Moving AverageBullishRSI […] (Read more...) The post TherapeuticsMD, Inc. breached its 50 day moving average in a Bearish Manner : TXMD-US : July 8, 2016 appeared first on CapitalCube.
TherapeuticsMD, Inc.NYSE MKT
After hours: 7.77-0.00 (-0.03%) as of 4:34 PM EDT
|Bid||7.77 x 100|
|Ask||9.00 x 800|
|52wk Range||5.18 - 11.26|
|Day's Range||7.68 - 8.06|
|Avg Vol (3m)||1,321,904|
As of 4:00 PM EDT. Market closed.